Loading...

The use of a novel non-steroidal mineralocorticoid receptor antagonist finerenone for the treatment of chronic heart failure: A systematic review and meta-analysis

BACKGROUND: The non-steroidal mineralocorticoid receptor antagonist finerenone (BAY 94–8862) has been used to treat chronic heart failure (CHF) with reduced ejection fraction (HFrEF). However, conflicting results were reported for its efficacy and safety. The study aimed to compare the efficacy and...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Medicine (Baltimore)
Main Authors: Pei, Hui, Wang, Wei, Zhao, Di, Wang, Lei, Su, Guo-Hai, Zhao, Zhuo
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5916685/
https://ncbi.nlm.nih.gov/pubmed/29668577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000010254
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!